Successful treatment of a patient with acute promyelocytic leukemia with a STAT5B/RARA fusion gene using decitabine

Leuk Lymphoma. 2018 Mar;59(3):763-765. doi: 10.1080/10428194.2017.1357176. Epub 2017 Aug 1.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Decitabine / therapeutic use*
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Leukemia, Promyelocytic, Acute / genetics*
  • Leukemia, Promyelocytic, Acute / pathology
  • Male
  • Middle Aged
  • Oncogene Proteins, Fusion / genetics*
  • Prognosis
  • STAT5 Transcription Factor / genetics*

Substances

  • Antimetabolites, Antineoplastic
  • Oncogene Proteins, Fusion
  • STAT5 Transcription Factor
  • STAT5-RARalpha protein, human
  • Decitabine